Second Sight Medical Products (EYES) 13.26

New Post Public Reply Private Reply Replies (0) Message Board

Apr 23, 2015 at 1:43 AM

Second Sight Medical Products (EYES) 13.26 $EYES

BUYINS.NET: EYES SqueezeTrigger Price is $14.49. There is $10,364,376 That Short Sellers Still Need To Cover.
M2 - Thu Apr 16, 3:06AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring VISION TWENTY-ONE INC (NASDAQ:EYES) in real time and just received an alert that EYES is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 713800 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $14.49. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
EYES: 13.26 (-0.06)

New Story On Second Sight Shows The Technology Is Gaining Traction
Edward Vranic, CFA - at Seeking Alpha - Wed Apr 15, 1:59PM CDT

EYES: 13.26 (-0.06)

A Recent IPO With A Medical Breakthrough For Blindness Worth Billions
Edward Vranic, CFA - at Seeking Alpha - Tue Apr 14, 9:49AM CDT

EYES: 13.26 (-0.06), ACAD: 38.55 (-0.20)

Second Sight Medical Sees 'Major Milestone'
at Investor's Business Daily - Wed Apr 08, 3:11PM CDT
Shares of Second Sight Medical Products (EYES) jumped Wednesday as the maker of implantable visual prosthetics reported successful test results in an animal study. Second Sight announced the first successful test of a mechanical model of its Orion I...
EYES: 13.26 (-0.06), RWLK: 13.09 (-0.04)

Second Sight Medical Products (EYES) Stock Rises Today on Positive Clinical Results
at The Street - Wed Apr 08, 11:25AM CDT
Second Sight Medical Products (EYES) shares are climbing after the company reported the first successful implant of its Orion I prosthetic today.
EYES: 13.26 (-0.06)

Why Second Sight Medical Products, Inc. Stock Bolted Higher Today
George Budwell, The Motley Fool - Motley Fool - Wed Apr 08, 10:11AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Second Sight Medical Products saw its shares rise...
EYES: 13.26 (-0.06)

Second Sight implants next-gen device in preclinical study; shares jump 20% premarket
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 8:14AM CDT

EYES: 13.26 (-0.06)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 8:12AM CDT

EYES: 13.26 (-0.06), PBR.A: 8.71 (+0.31), BALT: 1.61 (+0.08), LBIO: 12.50 (+0.50), RGLS: 17.40 (-0.22), ZEP: 19.95 (+0.02), WBAI: 16.75 (-0.46), PBR: 8.93 (+0.35), INO: 10.39 (-0.09), LGF: 31.24 (+0.10), CHL: 74.29 (-0.12), PSTR: 4.78 (+0.07), MPO: 1.16 (+0.04), CBMG: 32.14 (+2.21)

Second Sight Announces First Successful Implant of Model of Orion I Visual Cortical Prosthesis
GlobeNewswire - Wed Apr 08, 7:00AM CDT
Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"

, a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implant of a mechanical model of the Orion(TM) I Visual Cortical Prosthesis ("Orion I"

in an animal study.
EYES: 13.26 (-0.06)

Borrow Costs Elevated On CorMedix
Interactive Brokers - at Seeking Alpha - Tue Mar 17, 2:09AM CDT
CorMedix, Inc. (NYSEMKT: CRMD ) continues to be a difficult borrow as demand has far exceeded the lendable supply. Over the past two weeks the amount of shares traded in the cash market has been well above historical averages while the amount of...
CRMD: 8.86 (-0.28), EYES: 13.26 (-0.06), SHAK: 62.00 (+2.00), MELA: 1.52 (-0.14), GME: 40.24 (+0.16), AMRN: 2.34 (-0.05), AXN: 1.77 (+0.01), FXCM: 2.13 (+0.02), WBAI: 16.75 (-0.46), RESN: 3.77 (-0.06), WPRT: 4.39 (+0.01), RIG: 16.85 (-0.18), CYTX: 0.96 (-0.09), CEN: 16.93 (+0.07), CAPN: 6.99 (-0.29)

Why Second Sight Medical Products, Inc. Is Tumbling
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 12, 12:20PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What's happening: Shares in Second Sight...
EYES: 13.26 (-0.06)

Second Sight reports Q4 results
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 3:26PM CDT

EYES: 13.26 (-0.06)

Second Sight Reports Fourth Quarter and Year End 2014 Financial Results and Provides Business Update
Business Wire - Wed Mar 11, 3:01PM CDT
Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"

, a leading developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today reported financial results for the three- and twelve- month periods ended December 31, 2014.
EYES: 13.26 (-0.06)

Second Sight Medical Products (EYES) Stock Soars Today After Increasing Implant Success
at The Street - Thu Mar 05, 1:36PM CST
Shares of Second Sight Medical Products (EYES) jumped in afternoon trading after the company announced that two newly approved centers successfully completed their first commercial implants.
EYES: 13.26 (-0.06)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 11:45AM CST

CRMD: 8.86 (-0.28), EYES: 13.26 (-0.06), ECR: 6.01 (+0.01), CECE: 11.63 (+0.01), DRAM: 2.25 (-0.07), NVGN: 7.40 (-0.30), AMED: 26.07 (+0.03), VSLR: 14.33 (+0.36), MOMO: 11.20 (+0.20), GEF: 39.11 (+0.37), RNDY: 5.48 (-0.15), SMTC: 25.78 (+0.06), EVOK: 6.43 (-0.08), KYTH: 49.94 (+0.78), GERN: 4.20 (-0.04), LTRE: 1.38 (+0.10), ENRJ: 1.75 (+0.05), PEIX: 12.25 (-0.30), ALG: 62.93 (+0.64), CAPN: 6.99 (-0.29)

Second Sight's Euro Momentum
Dallas Salazar - at Seeking Alpha - Mon Mar 02, 7:02AM CST

EYES: 13.26 (-0.06)

Market Maker Surveillance Report. TTI, ABTL, AVEO, EYES, CLNE, XIN, Winning Stocks With Lowest Price Friction For Friday, February 27th 2015
M2 - Mon Mar 02, 5:29AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5214 companies with "abnormal" market making, 2975 companies with positive Friction Factors and 3319 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. TETRA Technologies Inc (NYSE:TTI), Autobytel Inc (NASDAQ:ABTL), Aveo Pharmaceuticals Inc (NASDAQ:AVEO), VISION TWENTY-ONE INC (NASDAQ:EYES), Clean Energy Fuels Corp (NASDAQ:CLNE), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
EYES: 13.26 (-0.06), ABTL: 16.20 (+0.98), XIN: 3.34 (+0.09), AVEO: 2.04 (+0.12), TTI: 7.15 (-0.02), CLNE: 7.16 (+0.03)

Why Second Sight Medical Products Inc. Vaulted Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 27, 12:41PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Al Mann's vision-restoring...
EYES: 13.26 (-0.06), MNKD: 4.90 (-0.09)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Patrick Ta Beauty Adds New Leadership to Expand Growth

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Investor Yazan Al Homsi Backs Arcanus Aerial for $500K

Yazan Al Homsi Backs Canadian Innovation Every once in a while, you see a move in the market that feels bigger than the numbers on the page. That's what this $500,000 from Yazan Al Homsi into Arcanus Aerial Systems does. Al Homsi, a UAE-based investor with a solid pedigree, decided to pump half a million bucks into Arcanus just as it's setting down roots in Canadian soil...

Acqualina Resort's Sustainable Commitment Earns Praise

Sustainability at the Heart of Luxury Spotlight's on Acqualina Resort again. The folks there have snagged the 2026 VERIFIED™ Responsible Hospitality badge from Forbes Travel Guide for the third straight year. Means they’re more than just a pretty face down in Miami. This accolade puts them slap bang among the best in sustainable luxury. Forbes doesn’t just hand...

Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

SLM Faces Legal Scrutiny as Losses Mount Amid Pause

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Better Home & Finance Faces Class Action: What's Next?

Stock Hit and Legal Drama Panic set in when Better Home & Finance Holding Company took a 28.5% nosedive after spilling some less-than-sweet news. Their promise of hitting a billion in monthly loans? Stuck in limbo as borrower trepidation reared its ugly head amidst rising rates. Investors felt the heat, watching shares skydive $12.17, landing them at a bruised $30.52. A...

Infosys Pushes AI Growth with Strong Deal Wins

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Italian Excellence: NYC Celebrates Innovators and Icons

The Fusion of Italian Artistry and Innovation Imagine blending business savvy with a touch of culture and ethics. That's the spirit of the 9th Business Care International Award, which is gearing up to hit New York City's grand stage come November 18-19. This ain't just about pats on the back; it's a recognition of those who push Italian excellence across oceans and into...

NUH Revolutionizes Eye Care with Multidisciplinary Clinics

Looking Back at Four Decades of Eye Care Excellence Sitting in the middle of Singapore, the National University Hospital's Ophthalmology Department has chalked up a solid 40 years serving up top-notch eye care. This ain't just about celebrating another year; it's about shaking things up with fresh approaches to treating tricky eye disorders. They're not resting on any...

Hi3D Unlocks AI 3D Model for Open-Source Innovation

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...